Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Preprečevanje, prepoznavanje in zdravljenje ekstravazacije citostatikov
Authors:ID Bernot, Marjana (Author)
ID Fortuna Lužar, Marijana (Author)
ID Borštnar, Simona (Author)
Files:.pdf PDF - Presentation file, download (604,32 KB)
MD5: 00343EC02725FFE2BB319CB3730859CB
PID: 20.500.12556/dirros/ff0a8840-3616-4f99-a469-dafd64b2203e
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Abstract:Ekstravazacija citostatikov je redek, vendar zelo neprijeten zaplet sistemskega zdravljenja raka. Ker lahko pripelje do hudih takojšnjih in poznih posledic za bolnika, zahteva posebno pozornost zdravstvenih delavcev, ki izvajajo intravenozno zdravljenje. V članku so zbrana priporočila za preprečevanje in prepoznavanje ekstravazacije, algoritem ukrepov ob njenem nastanku in možnosti uporabe antidotov.
Keywords:onkologija, zdravljenje, zapleti, ekstravazacija
Year of publishing:2011
Publication status in journal:Published
Article version:Publisher's version of article
Number of pages:str. 47-51
Numbering:Letn. 15, št. 1
PID:20.500.12556/DiRROS-8723 New window
ISSN on article:1408-1741
COBISS.SI-ID:1133179 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija : strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
COBISS.SI-ID:65324032 New window


License:CC BY 4.0, Creative Commons Attribution 4.0 International
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Title:Prevention, Detection and Treatment of Extravasation of Cytotoxic Agents
Abstract:Extravasation is a rare but very unpleasant complication of systemic cancer treatment and could be the cause of severe early and delayed consequences for the patient. Extravasation warrants special attention from the healthcare professionals involved in administering intravenous medications. The article summarizes and explains the most recent recommendations on extravasation in the clinical setting - from prevention and recognition to possible treatments with antidotes.